ML21057A005

Shine Medical Technologies. LLC Application for an Operating License Commitment Change Related to the Submission of a Revision to the Technical Specifications

ML21057A005
Person / Time
Site:	SHINE Medical Technologies
Issue date:	02/26/2021
From:	Jim Costedio SHINE Medical Technologies
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
2021-SMT-0026
Download: ML21057A005 (2)

Text

February 26, 2021 2021-SMT-0026 10 CFR 50.30 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555

References:

(1) SHINE Medical Technologies, LLC. letter to NRC, dated July 17, 2019, SHINE Medical Technologies, LLC Application for an Operating License (ML19211C143)

(2) SHINE Medical Technologies, LLC. letter to NRC, dated December 10, 2020, SHINE Medical Technologies, LLC Operating License Application Supplement No. 5 and Response to Request for Additional Information (3) SHINE Medical Technologies, LLC. letter to NRC, dated December 15, 2020, SHINE Medical Technologies, LLC Operating License Application Supplement No. 6 and Response to Request for Additional Information (4) SHINE Medical Technologies, LLC. letter to NRC, dated January 29, 2021, SHINE Medical Technologies, LLC Operating License Application Response to Request for Additional Information (5) NRC electronic mail to SHINE Medical Technologies, LLC, dated January 27, 2021, Issuance of Request for Additional Information Related to the SHINE Medical Technologies, LLC Operating License Application (EPID No. L-2019-NEW-0004)

SHINE Medical Technologies. LLC Application for an Operating License Commitment Change Related to the Submission of a Revision to the Technical Specifications Pursuant to 10 CFR 50.30, SHINE Medical Technologies, LLC. (SHINE) submitted an application for an operating license for a medical isotope facility located in Janesville, Wisconsin (Reference 1).

Via References (2), (3), and (4), SHINE made commitments to provide a revision to the technical specifications incorporating the mark-ups provided in each reference by February 28, 2021. SHINE has determined that additional time is needed to incorporate technical specification changes resulting from the SHINE responses to requests for additional information (Reference 5) currently in progress. Therefore, the commitment date is changed to March 31, 2021.

If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.

101 E. Milwaukee Street, Suite 600 l Janesville, WI 53545 l P (608) 210-1060 l F (608) 210-2504 l www.shinemed.com

Document Control Desk Page 2 Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Medical Technologies, LLC Docket No. 50-608 cc:

Project Manager, USNRC Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health SHINE General Counsel